BACKGROUND: Inflammatory cytokines dysregulate microvascular function, yet how cytokines affect lymphatic endothelial cells (LEC) are unclear. METHODS AND RESULTS: We examined effects of TNF-α, IL-1 beta, and IFN-gamma on LEC proliferation, endothelial cell adhesion molecule (ECAM) expression, capillary formation, and barrier changes in murine (SV-LEC) and human LECs (HMEC-1a). RESULTS: All cytokines induced ICAM-1, VCAM-1, MAdCAM-1, and E-selectin in SV-LECs; TNF-α, IL-1 beta; and IFN-gamma induced ECAMs (but not MAdCAM-1) in HMEC-1a. IL-1 beta increased, while IFN-gamma and TNF-α reduced SV-LEC proliferation. While TNF-α induced, IFN-gamma decreased, and IL-1 beta did not show any effect on HMEC-1a proliferation. TNF-α, IL-1 beta, and IFN-gamma each reduced capillary formation in SV-LEC and in HMEC-1a. TNF-α and IL-1 beta reduced barrier in SV-LEC and HMEC-1a; IFN-gamma did not affect SV-LEC barrier, but enhanced HMEC-1a barrier. Inflammatory cytokines alter LEC growth, activation and barrier function in vitro and may disturb lymphatic clearance increasing tissue edema in vivo. CONCLUSION: Therapies that maintain or restore lymphatic function (including cytokines blockade), may represent important strategies for limiting inflammation.
BACKGROUND: Inflammatory cytokines dysregulate microvascular function, yet how cytokines affect lymphatic endothelial cells (LEC) are unclear. METHODS AND RESULTS: We examined effects of TNF-α, IL-1 beta, and IFN-gamma on LEC proliferation, endothelial cell adhesion molecule (ECAM) expression, capillary formation, and barrier changes in murine (SV-LEC) and human LECs (HMEC-1a). RESULTS: All cytokines induced ICAM-1, VCAM-1, MAdCAM-1, and E-selectin in SV-LECs; TNF-α, IL-1 beta; and IFN-gamma induced ECAMs (but not MAdCAM-1) in HMEC-1a. IL-1 beta increased, while IFN-gamma and TNF-α reduced SV-LEC proliferation. While TNF-α induced, IFN-gamma decreased, and IL-1 beta did not show any effect on HMEC-1a proliferation. TNF-α, IL-1 beta, and IFN-gamma each reduced capillary formation in SV-LEC and in HMEC-1a. TNF-α and IL-1 beta reduced barrier in SV-LEC and HMEC-1a; IFN-gamma did not affect SV-LEC barrier, but enhanced HMEC-1a barrier. Inflammatory cytokines alter LEC growth, activation and barrier function in vitro and may disturb lymphatic clearance increasing tissue edema in vivo. CONCLUSION: Therapies that maintain or restore lymphatic function (including cytokines blockade), may represent important strategies for limiting inflammation.
Authors: Jeremy Goldman; Joseph M Rutkowski; Jacqueline D Shields; Miriella C Pasquier; Yingjie Cui; Hugo G Schmökel; Stephen Willey; Daniel J Hicklin; Bronislaw Pytowski; Melody A Swartz Journal: FASEB J Date: 2007-01-08 Impact factor: 5.191
Authors: T Ando; P Jordan; Y Wang; M Itoh; T Joh; M Sasaki; J W Elrod; A Carpenter; M H Jennings; A Minagar; J S Alexander Journal: Inflamm Bowel Dis Date: 2005-03 Impact factor: 5.325
Authors: T Oshima; F S Laroux; L L Coe; Z Morise; S Kawachi; P Bauer; M B Grisham; R D Specian; P Carter; S Jennings; D N Granger; T Joh; J S Alexander Journal: Microvasc Res Date: 2001-01 Impact factor: 3.514
Authors: K Polzer; D Baeten; A Soleiman; J Distler; D M Gerlag; P P Tak; G Schett; J Zwerina Journal: Ann Rheum Dis Date: 2008-01-03 Impact factor: 19.103
Authors: Jodi L Murakami; Baohui Xu; Christopher B Franco; Xingbin Hu; Stephen J Galli; Irving L Weissman; Ching-Cheng Chen Journal: Stem Cells Dev Date: 2015-11-05 Impact factor: 3.272
Authors: Karina M Lugo-Cintrón; José M Ayuso; Bridget R White; Paul M Harari; Suzanne M Ponik; David J Beebe; Max M Gong; María Virumbrales-Muñoz Journal: Lab Chip Date: 2020-04-16 Impact factor: 6.799